Search - Université de Rennes Access content directly

Filter your results

11 Results
authFullName_s : François Habersetzer
Image document

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Sébastien Dharancy , Audrey Coilly , Claire Fougerou-Leurent , Christophe Duvoux , Nassim Kamar et al.
American Journal of Transplantation, 2017, 17 (11), pp.2869-2878. ⟨10.1111/ajt.14490⟩
Journal articles hal-01640061v1

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Audrey Coilly , Jean-Charles Duclos-Vallee et al.
Journal of Hepatology, 2019, 70 (6), pp.1297-1300. ⟨10.1016/j.jhep.2019.02.019⟩
Journal articles hal-02120675v1

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

Audrey Coilly , Claire Fougerou-Leurent , Victor De Ledinghen , Pauline Houssel-Debry , Christophe Duvoux et al.
Journal of Hepatology, 2016, 65 (4), pp.711--718. ⟨10.1016/j.jhep.2016.05.039⟩
Journal articles hal-01395132v1
Image document

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study

Fabrice Carrat , Hélène Fontaine , Céline Dorival , Mélanie Simony , Alpha Diallo et al.
The Lancet, 2019, 393 (10179), pp.1453-1464. ⟨10.1016/S0140-6736(18)32111-1⟩
Journal articles hal-02050395v1
Image document

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients

Stanislas Pol , Marc Bourlière , Sandy Lucier , Christophe Hézode , Céline Dorival et al.
Journal of Hepatology, 2017, 66 (1), pp.39-47. ⟨10.1016/j.jhep.2016.08.021⟩
Journal articles hal-01435007v1

No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Jean-Charles Duclos-Vallee , Christophe Duvoux et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles hal-01769634v1

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).

Marc Bourlière , Jean-Pierre Bronowicki , Victor de Ledinghen , Christophe Hézode , Fabien Zoulim et al.
The Lancet Infectious Diseases, 2015, 15 (4), pp.397-404. ⟨10.1016/S1473-3099(15)70050-2⟩
Journal articles hal-01134440v1
Image document

Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study

Laurent Lam , Hélène Fontaine , Marc Bourliere , Clovis Lusivika-Nzinga , Céline Dorival et al.
Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (5), pp.101713. ⟨10.1016/j.clinre.2021.101713⟩
Journal articles hal-03224103v1

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Journal articles hal-01412958v1

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2018, 68 (4), pp.1277-1287. ⟨10.1002/hep.29918⟩
Journal articles hal-01807755v1
Image document

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Georges‐philippe Pageaux , Clovis Lusivika Nzinga , Nathalie Ganne , Didier Samuel , Céline Dorival et al.
BMC Infectious Diseases, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
Journal articles hal-03555553v1